Nifty
:
23587.50
Sensex
:
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)
Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Max Healthcare Institute Ltd.

Hospital & Healthcare Services

Rating :
N/A

BSE: 543220 | NSE: MAXHEALTH

NSE BSE
1165.20
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1180.70
  •  1200.00
  •  1159.75
  •  1180.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3690684
  •  43426.93
  •  1215.55
  •  651.40

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,13,408.93
  • 107.09
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,13,309.48
  • 0.13%
  • 12.89

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 23.74%
  • 0.16%
  • 3.18%
  • FII
  • DII
  • Others
  • 57.29%
  • 14.45%
  • 1.18%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.91
  • 38.55
  • 11.15

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 34.72
  • 73.73
  • 9.56

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 141.37
  • 20.46

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 62.86

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 7.72

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 41.57

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
10.89
14.7
19.39
23.92
P/E Ratio
92.39
68.46
51.88
42.05
Revenue
5309
7943
10170
12210
EBITDA
1492
2218
2869
3491
Net Income
1058
1402
1851
2297
ROA
9.6
11
12.2
14
P/Bk Ratio
11.63
9.3
7.97
6.76
ROE
13.37
14.42
16.22
17.27
FCFF
316.81
92.05
896.97
1365.26
FCFF Yield
0.33
0.1
0.93
1.42

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
1,707.46
1,363.16
25.26%
1,542.95
1,284.99
20.07%
1,422.90
1,214.51
17.16%
1,334.97
1,141.78
16.92%
Expenses
1,256.92
975.81
28.81%
1,155.54
947.61
21.94%
1,041.37
874.17
19.13%
949.11
827.79
14.66%
EBITDA
450.54
387.35
16.31%
387.41
337.38
14.83%
381.53
340.34
12.10%
385.86
313.99
22.89%
EBIDTM
26.39%
28.42%
25.11%
26.26%
26.81%
28.02%
28.90%
27.50%
Other Income
40.84
45.48
-10.20%
34.68
41.32
-16.07%
45.25
40.22
12.51%
46.02
44.61
3.16%
Interest
33.54
8.53
293.20%
23.88
19.39
23.16%
20.73
19.53
6.14%
11.24
20.13
-44.16%
Depreciation
84.15
57.88
45.39%
76.90
55.82
37.76%
70.32
60.35
16.52%
60.96
57.03
6.89%
PBT
373.69
366.42
1.98%
321.31
303.49
5.87%
335.73
300.68
11.66%
359.68
281.44
27.80%
Tax
91.88
89.74
2.38%
85.04
63.41
34.11%
84.19
49.76
69.19%
70.34
59.03
19.16%
PAT
281.81
276.68
1.85%
236.27
240.08
-1.59%
251.54
250.92
0.25%
289.34
222.41
30.09%
PATM
16.50%
20.30%
15.31%
18.68%
17.68%
20.66%
21.67%
19.48%
EPS
2.90
2.85
1.75%
2.43
2.47
-1.62%
2.59
2.58
0.39%
2.98
2.29
30.13%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 16
Mar 15
Mar 14
Net Sales
6,008.28
5,406.02
4,562.60
3,936.55
2,507.97
1,059.03
1,691.02
1,445.40
1,133.61
944.46
Net Sales Growth
20.06%
18.49%
15.90%
56.96%
136.82%
-37.37%
16.99%
27.50%
20.03%
 
Cost Of Goods Sold
1,238.68
1,118.52
922.01
922.90
594.41
217.31
364.46
398.63
345.95
328.00
Gross Profit
4,769.60
4,287.50
3,640.59
3,013.65
1,913.56
841.72
1,326.56
1,046.77
787.66
616.46
GP Margin
79.38%
79.31%
79.79%
76.56%
76.30%
79.48%
78.45%
72.42%
69.48%
65.27%
Total Expenditure
4,402.94
3,924.88
3,335.14
2,998.14
2,124.34
965.45
1,545.51
1,329.79
1,058.39
914.52
Power & Fuel Cost
-
77.54
69.04
62.67
51.37
22.72
46.06
40.73
32.60
29.63
% Of Sales
-
1.43%
1.51%
1.59%
2.05%
2.15%
2.72%
2.82%
2.88%
3.14%
Employee Cost
-
934.40
809.35
759.92
588.78
230.13
440.55
297.48
232.09
188.81
% Of Sales
-
17.28%
17.74%
19.30%
23.48%
21.73%
26.05%
20.58%
20.47%
19.99%
Manufacturing Exp.
-
1,348.42
1,195.50
995.21
670.35
336.05
112.01
16.97
293.99
244.08
% Of Sales
-
24.94%
26.20%
25.28%
26.73%
31.73%
6.62%
1.17%
25.93%
25.84%
General & Admin Exp.
-
382.92
303.70
226.23
165.14
129.84
563.52
476.29
142.24
114.53
% Of Sales
-
7.08%
6.66%
5.75%
6.58%
12.26%
33.32%
32.95%
12.55%
12.13%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
28.30
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
1.96%
0%
0%
Miscellaneous Exp.
-
63.08
35.54
31.21
54.29
29.40
18.91
99.69
11.52
9.47
% Of Sales
-
1.17%
0.78%
0.79%
2.16%
2.78%
1.12%
6.90%
1.02%
1.00%
EBITDA
1,605.34
1,481.14
1,227.46
938.41
383.63
93.58
145.51
115.61
75.22
29.94
EBITDA Margin
26.72%
27.40%
26.90%
23.84%
15.30%
8.84%
8.60%
8.00%
6.64%
3.17%
Other Income
166.79
189.05
152.31
131.51
134.97
48.08
66.72
29.78
27.27
23.48
Interest
89.39
59.89
83.86
100.87
179.46
83.24
101.27
73.06
61.16
62.25
Depreciation
292.33
244.98
232.19
221.12
174.09
45.64
102.64
86.62
78.38
55.46
PBT
1,390.41
1,365.32
1,063.72
747.93
165.05
12.78
8.32
-14.29
-37.05
-64.29
Tax
331.45
307.68
-39.79
133.85
45.85
-0.13
8.51
-0.02
0.00
0.36
Tax Rate
23.84%
22.54%
-3.74%
18.11%
-66.79%
-1.02%
102.28%
0.14%
0.00%
-0.56%
PAT
1,058.96
1,057.64
1,103.51
605.05
-114.50
12.91
-3.01
-13.77
-37.05
-64.65
PAT before Minority Interest
1,058.96
1,057.64
1,103.51
605.05
-114.50
12.91
-0.19
-14.27
-37.05
-64.65
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-2.82
0.50
0.00
0.00
PAT Margin
17.63%
19.56%
24.19%
15.37%
-4.57%
1.22%
-0.18%
-0.95%
-3.27%
-6.85%
PAT Growth
6.96%
-4.16%
82.38%
-
-
-
-
-
-
 
EPS
10.89
10.88
11.35
6.22
-1.18
0.13
-0.03
-0.14
-0.38
-0.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
8,408.14
7,409.59
6,282.47
5,638.68
2,553.15
963.19
Share Capital
971.91
970.92
969.61
965.95
537.24
537.24
Total Reserves
7,368.75
6,397.04
5,290.74
4,646.22
2,015.91
425.95
Non-Current Liabilities
2,343.09
1,646.69
2,149.39
2,127.85
410.56
1,251.32
Secured Loans
1,060.33
496.08
628.91
842.32
105.73
889.10
Unsecured Loans
0.50
0.50
0.50
0.50
0.50
0.96
Long Term Provisions
75.47
60.48
59.79
60.19
40.66
18.02
Current Liabilities
1,248.71
1,045.57
757.27
776.93
1,009.95
1,140.03
Trade Payables
677.47
543.46
444.11
435.69
179.63
291.59
Other Current Liabilities
448.80
408.16
196.95
237.52
95.26
752.87
Short Term Borrowings
61.29
45.58
74.53
54.25
727.37
77.61
Short Term Provisions
61.15
48.37
41.68
49.47
7.69
17.96
Total Liabilities
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54
Net Block
8,720.66
7,038.70
7,017.58
6,536.38
850.95
2,192.37
Gross Block
9,902.43
7,958.37
7,759.60
7,099.22
1,252.16
2,557.37
Accumulated Depreciation
1,181.77
919.67
742.02
562.84
401.21
365.00
Non Current Assets
10,293.76
8,158.78
8,188.84
7,418.99
1,058.27
2,907.24
Capital Work in Progress
553.04
252.43
151.12
26.93
27.55
87.02
Non Current Investment
2.12
0.51
0.51
0.51
0.00
0.51
Long Term Loans & Adv.
727.51
673.93
757.17
679.63
70.06
535.51
Other Non Current Assets
227.40
193.21
262.46
175.54
109.71
91.83
Current Assets
1,706.18
1,943.07
1,000.29
1,124.47
2,915.39
447.30
Current Investments
0.00
0.00
0.00
0.00
2,182.06
0.00
Inventories
79.84
76.23
61.36
53.80
26.80
26.01
Sundry Debtors
462.69
336.12
385.36
365.89
96.09
362.61
Cash & Bank
1,099.27
1,468.07
499.31
652.92
119.57
11.64
Other Current Assets
64.38
14.06
23.99
14.47
490.87
47.04
Short Term Loans & Adv.
40.79
48.59
30.27
37.39
478.76
36.06
Net Current Assets
457.47
897.50
243.02
347.54
1,905.44
-692.73
Total Assets
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
1,121.80
1,284.13
740.52
117.86
77.09
88.95
PBT
1,365.32
1,063.72
738.90
-68.65
12.78
8.32
Adjustment
184.85
225.84
241.22
504.74
109.44
156.89
Changes in Working Capital
-159.09
155.69
-130.54
-376.25
-38.84
-48.13
Cash after chg. in Working capital
1,391.08
1,445.25
849.58
59.84
83.38
117.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-269.28
-161.12
-109.06
58.02
-6.29
-28.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,285.45
-102.32
-763.80
-73.00
-2,640.70
-16.53
Net Fixed Assets
-450.48
-140.69
-1,687.37
-2,982.65
557.88
Net Investments
-440.62
-27.73
932.29
91.94
-1,701.27
Others
-394.35
66.10
-8.72
2,817.71
-1,497.31
Cash from Financing Activity
-263.74
-288.56
-294.17
191.33
2,353.12
-73.95
Net Cash Inflow / Outflow
-427.39
893.25
-317.45
236.19
-210.49
-1.53
Opening Cash & Equivalents
1,374.33
480.97
626.59
111.01
321.50
9.13
Closing Cash & Equivalent
979.84
1,374.33
309.14
626.59
111.01
7.60

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
85.82
75.89
64.57
58.10
47.52
17.93
ROA
9.57%
11.44%
6.82%
-1.83%
0.35%
-0.01%
ROE
13.47%
16.19%
10.19%
-2.80%
0.73%
-0.02%
ROCE
16.26%
15.32%
12.38%
2.22%
3.57%
5.32%
Fixed Asset Turnover
0.61
0.58
0.53
0.60
0.56
0.67
Receivable days
26.97
28.86
34.83
33.62
79.05
66.97
Inventory Days
5.27
5.50
5.34
5.87
9.10
5.86
Payable days
199.21
195.48
173.98
188.92
99.45
94.83
Cash Conversion Cycle
-166.97
-161.11
-133.81
-149.44
-11.30
-22.01
Total Debt/Equity
0.14
0.08
0.12
0.16
0.33
1.05
Interest Cover
23.80
13.68
8.33
0.62
1.15
1.08

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Max Healthcare Institute completes acquisition of 100% equity stake of Jaypee Healthcare
    12th Nov 2024, 10:13 AM

    Consequently, JHL has become a wholly-owned subsidiary of the Company

    Read More
  • Max Healthcare Institute to acquire 63.65% stake in Jaypee Healthcare
    27th Sep 2024, 10:12 AM

    The company has executed SPA with Jaypee Infratech and Lakshdeep Group for acquisition

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.